← Open Payments lookup

STACEY WAGGONER: Open Payments

NPI 1285008227 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,803 in 109 payments from 13 companies in 2025. Trend: 2023 $2,070 · 2024 $1,721 · 2025 $1,803

Food & beverage: $1,803
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.26$371
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$249
Vanda Pharmaceuticals Inc.14$236
Janssen Pharmaceuticals, Inc15$219
Otsuka America Pharmaceutical, Inc.13$204
Alkermes, Inc.6$142
Lundbeck LLC4$102
Neurocrine BioSciences, Inc.4$64
ABBVIE INC.3$51
Takeda Pharmaceuticals U.S.A., Inc.2$48

Products named: CAPLYTA, FANAPT, AUSTEDO XR, UZEDY, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, LYBALVI.

Industry payments across OK — which companies pay providers there.